Comparative Treatment Cost Between Warfarin And Novel Oral Anticoagulants (NOACS) In Non-Valvular Atrial Fibrillation (NVAF) Patients- A Pilot Study From A Malaysia State Hospital Perspective
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.219
https://www.valueinhealthjournal.com/article/S1098-3015(18)32576-2/fulltext
Title :
Comparative Treatment Cost Between Warfarin And Novel Oral Anticoagulants (NOACS) In Non-Valvular Atrial Fibrillation (NVAF) Patients- A Pilot Study From A Malaysia State Hospital Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32576-2&doi=10.1016/j.jval.2018.07.219
First page :
Section Title :
Open access? :
No
Section Order :
207